Second-trimester Maternal Serum Quadruple Test for Down Syndrome Screening: A Taiwanese Population-based Study

Taiwanese Journal of Obstetrics and Gynecology

Volumn 49, Issue 1, 2010, Pages 30-34

  Shaw, S W Steven ^a,b   Lin, Shin Yu ^c   Lin, Chia Hui ^c   Su, Yi Ning ^c   Cheng, Po Jen ^a   Lee, Chien Nan ^c   Chen, Chih Ping ^d,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Department of Obstetrics and Gynecology ^*  (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Down syndrome; quadruple test; second trimester

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

ADULT; AMNIOCENTESIS; ARTICLE; DOWN SYNDROME; ETHNICITY; FEASIBILITY STUDY; FEMALE; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; NEWBORN; POPULATION RESEARCH; PRENATAL SCREENING; PROTEIN BLOOD LEVEL; RELIABILITY; SECOND TRIMESTER PREGNANCY; TAIWAN;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; INHIBINS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; TAIWAN;

EID: 77953282002     PISSN: 10284559     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(10)60005-8     Document Type: Article

References (17)

1. Hsu J.J., Hsieh T.T., and Hsieh F.J. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol 87 (1996) 943-947
2. Jou H.J., Shyu M.K., Chen S.M., Shih J.C., Hsu J.J., and Hsieh F.J. Maternal serum screening for Down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an Asian population: a prospective study. Fetal Diagn Ther 15 (2000) 108-111
3. Shaw S.W., Hsu J.J., Lee C.N., Hsiao C.H., Chen C.P., Hsieh T.T., and Cheng P.J. First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. Taiwan J Obstet Gynecol 47 (2008) 157-162
4. Jou H.J., Kuo Y.S., Hsu J.J., Shyu M.K., Hsieh T.T., and Hsieh F.J. The evolving national birth prevalence of Down syndrome in Taiwan: a study on the impact of second-trimester maternal serum screening. Prenat Diagn 25 (2005) 665-670
5. Hwa H.L., Yen M.F., Lin C.L., Ko T.M., Hsieh F.J., and Chen T.H. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women. J Eval Clin Pract 14 (2008) 191-197
6. Tovanabutra S., Illingworth P.J., Ledger W.L., Glasier A.F., and Baird D.T. The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy. Clin Endocrinol (Oxf) 38 (1993) 101-107
7. Minami S., Yamoto M., and Nakano R. Sources of inhibin in early pregnancy. Early Pregnancy 1 (1995) 62-66
8. Van Lith J.M., Pratt J.J., Beekhuis J.R., and Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 12 (1992) 801-806
9. Cuckle H.S., Holding S., and Jones R. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Prenat Diagn 14 (1994) 387-390
10. Wald N.J., Densem J.W., George L., Muttukrishna S., and Knight P.G. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 16 (1996) 143-153
11. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 353 (2005) 2001-2011
12. American College of Obstetrics and Gynecologists. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109 (2007) 217-227
13. Rawlins M.L., La'ulu S.L., Erickson J.A., and Roberts W.L. Performance characteristics of the Access Inhibin A assay. Clin Chim Acta 397 (2008) 32-35
14. Lam Y.H., and Tang M.H. Second-trimester maternal serum inhibin-A screening for fetal Down syndrome in Asian women. Prenat Diagn 19 (1999) 463-467
15. Lambert-Messerlian G.M., Palomaki G.E., and Canick J.A. Inhibin A measurement using an automated assay platform. Prenat Diagn 28 (2008) 399-403
16. Wald N.J., Huttly W.J., and Hackshaw A.K. Antenatal screening for Down's syndrome with the quadruple test. Lancet 361 (2003) 835-836
17. Tseng J.J., Chou M.M., Lo F.C., Lai H.Y., Chen M.H., and Ho E.S. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004. Taiwan J Obstet Gynecol 45 (2006) 39-41